Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Change Agents Corporation.ALBT · Entity 8466 | Interim CEO | June 29, 2026 | July 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Change Agents Corporation.
Report date June 29, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2029-06-29 | Direct | 402,000 |
Reported balance
After 2026-06-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-29 · Grant · Acquired 400,000 · Balance 402,000 F1: One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2026 Filed Jul 13, 2026 20:31 UTC | Change Agents Corporation. ALBT · Entity 8466 | GrantOptions (right to buy) · Derivative | 400,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001213900-26-077595 · ownership.xml · derivative · entry 1 Li Meng · CIK 0001688011 · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,000 Underlying: Common Stock · 400,000 shares Expires 2029-06-29 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 21:06 UTC | Change Agents Corporation. AVCO · Entity 8466 | GrantStock Options · Derivative | 300,000 | $1.52 Strike: $1.52 | $456,000.00 |
DisclosureSEC source: 0001213900-20-004737 · ownership.xml · derivative · entry 2 Li Meng · CIK 0001688011 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock, $.0001 par value · 300,000 shares Expires 2020-02-25 F1 · security: The stock options vest over one year in equal quarterly installments. Read SEC document |
| April 05, 2019 Filed Apr 9, 2019 19:45 UTC | Change Agents Corporation. AVCO · Entity 8466 | GrantStock Option · Derivative | 30,000 | $4.76 Strike: $4.76 | $142,800.00 |
DisclosureSEC source: 0001213900-19-006043 · ownership.xml · derivative · entry 2 Li Meng · CIK 0001688011 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock, $.0001 par value · 30,000 shares Expires 2024-04-05 F1 · security: On April 5, 2019, Meng Li was appointed to the Board of Directors of Avalon GloboCare Corp. (the "Company") to serve as director of the Company. Ms. Li entered into an agreement pursuant to which she will serve as a director of the Company. The director agreement provides that Ms. Li will receive options to receive 40,000 shares of common stock per year at an exercise price equal to the closing price on December 31st of the prior year vesting quarterly. The options shall vest in equal amounts quarterly and shall be exercisable for a period of five years. For 2019, the Company granted Ms. Li an option to acquire 30,000 shares of common stock at an exercise price of $4.76 for a term of five years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.